Web Exclusives

The updated prostate cancer guideline issued by the National Comprehensive Cancer Network (NCCN) continues to support early detection efforts in well-informed, healthy men, but acknowledges that the optimal screening of high-risk patients is not completely known. Read Article ›

This issue of Rheumatology Practice Management (RPM) provides a sneak peek at some of the “Hidden Treasures of Rheumatology” that await attendees of this year’s conference. Read Article ›

A strange-looking pirate has been seen lurking around the National Organization of Rheumatology Managers, and rumor has it that he is searching for treasures that we have hidden for you, the rheumatology practice manager. Make sure to claim your share at the 13th annual NORM Conference, October 4-6, 2018, in Tampa, FL! Read Article ›

The addition of abiraterone acetate (Zytiga) to androgen-­deprivation therapy (ADT) did not increase medical resource utilization in patients with metastatic castration-naïve prostate cancer who participated in the multinational LATITUDE clinical trial. Read Article ›

NORM is here to partner with you to chart a course of continued success and sustainability. Change is never easy, but in the rheumatology world, it is a constant. Preparing our physicians and staff to anticipate changes and effectively navigate them is part of our job as leaders within our practices.

Read Article ›


According to the results of 2 separate clinical trials presented at the 2018 Genitourinary Cancers Symposium, apalutamide and enzalutamide reduced the risk for metastasis and prolonged metastasis-free survival in patients with nonmetastatic castrate-resistant prostate cancer.

Read Article ›

Our news blog is comprised of several categories, including Healthy Lifestyle, Holidays, Industry News, Minute with the Board, NORM Events, NORM News, Resources, Social Media, and Tips and Tricks.

Read Article ›

  • Ixekizumab Approved for Adults with Psoriatic Arthritis
  • Biosimilar to Infliximab Approved for All Eligible Indications of Reference Drug
  • Tofacitinib and Tofacitinib Extended Release Approved for Adults with Psoriatic Arthritis
Read Article ›

Happy holidays and warmest wishes to you and your staff from the National Organization of Rheumatology Managers (NORM)!

Read Article ›


In a recent interview, Ms Zlatkus shared comments about her aspirations as President of NORM and Editor-in-Chief of RPM.

Read Article ›

Page 2 of 5

Subscribe to
Urology Practice Management

Stay up to date with urology news & updates by subscribing to recieve the free UPM print publications or weekly e‑Newsletter.

I'd like to recieve: